Navigation Links
Cempra Expands Clinical Management Team to Advance Leading Antibacterial Clinical Programs Solithromycin and TAKSTA™
Date:3/3/2011

development.  

Jennifer Shranz, M.D., vice president, clinical affairs for Cempra, added, "Our two leading clinical candidates are rapidly progressing to pivotal trials.  In addition, each has several promising applications beyond the lead indications that we are studying presently.  Bringing on these experienced pharmaceutical professionals will help us to both prioritize follow-on indications as well as expertly design all of our clinical development programs."  

About Cempra PharmaceuticalsFounded in 2006, Cempra Pharmaceuticals is a privately-held, clinical-stage pharmaceutical company focused on developing antibacterials to address critical medical needs. Two lead products, both in late-stage clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. Cempra is well-funded and is committed to developing commercially and medically differentiated and novel products that reduce development risk and provide a high financial return. The company is also utilizing its proprietary compound library and chemistry technology to develop novel macrolides without antibacterial activity for non-antibiotic uses such as COPD, chronic inflammatory and GI disorders. Additional information about Cempra can be found at www.cempra.com.Media Contacts:Russo Partners, LLCRobert E. Flamm, Ph.D.(212) 845-4226 Robert.flamm@russopartnersllc.comTony Russo, Ph.D.(212) 845-4251Tony.russo@russopartnersllc.com
'/>"/>

SOURCE Cempra Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Presented on Cempra Pharmaceuticals CEM-101 at the Infectious Diseases Society of America Annual Meeting Reinforces Potency and Coverage Against Multidrug-Resistant S. Pneumoniae Isolates
2. Presentations of Cempra Pharmaceuticals CEM-102 (fusidic acid) at the Infectious Diseases Society of America Annual Meeting Highlight Properties That Make It an Excellent Anti-MRSA Candidate
3. Cempra Pharmaceuticals To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17th
4. Cempra Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
5. Cempra Pharmaceuticals to Present at the UBS Global Life Sciences Conference
6. Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
7. Cempra Pharmaceuticals Names Carl Foster Executive Vice President of Business Development
8. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
9. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
10. Cellectar Expands Clinical Management Team
11. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ATLANTA , Sept. 4, 2015 Today, ... the launch of Prescription Drug Overdose: Prevention for ... the ongoing prescription drug overdose epidemic. The Prevention ... Department of Health and Human Services, Opioid Initiative, will ... the resources and expertise they need to help prevent ...
(Date:9/4/2015)... , Sept. 4, 2015  Essilor is pleased ... millennials, greatest defense against the eyestrain that comes with ... intended to serve as an everyday pair of glasses ... people who are on smart phones, tablets and computers ... benefit those who require a prescription but also those ...
(Date:9/4/2015)... AUSTIN, Texas , Sept. 4, 2015  Luminex ... will present at the Morgan Stanley Global Healthcare Conference ... the Grand Hyatt Hotel in New York ... begin at 11:40 a.m. Eastern time on Friday, September ... be accessed at Luminex Corporation,s website at http://www.luminexcorp.com ...
Breaking Medicine Technology:CDC funding helps states combat prescription drug overdose epidemic 2CDC funding helps states combat prescription drug overdose epidemic 3Essilor Launches New Eyezen Glasses Specifically Designed For A Digital Focused Audience 2Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2
... Fla., May 30, 2012 Nouveau Life Pharmaceuticals, Inc. ... action to change its name from Hybrid Fuels, Inc.  ... effective on May 22, 2012.  The trading symbol for ... The name Nouveau Life Pharmaceuticals more ...
... Canon, the Global MedTech Authority, has announced an upcoming online event ... This event, Emerging Trends in Medical Device Outsourcing/Contract Manufacturing , ... ( MD+DI ), Medical Product ... China Medical Device Manufacturer ( CMDM ), ...
Cached Medicine Technology:Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc. 2MD+DI, MPMN, Qmed and CMDM Announce Emerging Trends in Medical Device 2MD+DI, MPMN, Qmed and CMDM Announce Emerging Trends in Medical Device 3
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... The Schmidt ... of Tanya De La Paz. , Schmidt National Law Group, a leading firm ... District of California against Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates for ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... Consumer Health Products Association (CHPA) joint meeting of its Product, Quality and Manufacturers, ... hazardous waste handling rules constantly evolving in the consumer goods industry, it can ...
(Date:9/4/2015)... ... September 04, 2015 , ... “Getting away from the daily ... to explore, revitalize and strengthen their ‘couple-ness,’” says Jean Claude Wietzel, general manager ... Seasons Resort Maui, the island’s only Forbes Five Star resort and Travel + Leisure’s ...
(Date:9/4/2015)... Portland, ME (PRWEB) , ... September 04, 2015 ... ... Symposium focus on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 ... ihsymposium.com/focus-event. , Speakers at the 2015 symposium are doctors and researchers at the ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... pale in comparison to settlements under the Stark physician self-referral law. “Stark ... Sept. 17 webinar from Atlantic Information Services, Inc. (AIS), will detail which deals ...
Breaking Medicine News(10 mins):Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2
... B1) states that a deficiency in vitamin B1 could ... treat obesity//. This is based on a study published ... of Neurology. ,The study further elucidates ... Wernicke’s encephalopathy, a severe neurological condition. ,Women ...
... or sell Viagra, as they fear it may result in ... ,"We will not sale the drug as it may lead ... problems," said Amar Sinha, general secretary of the Jharkhand Chemist ... added: "The common practice here is to sell medicines even ...
... Resorts has banned smoking in the rooms, restaurants, bars and ... and the Caribbean from January 2006//., ,Guests will only ... areas. , ,Westin said research among its customers had ... , ,"Nobody likes to walk into a smoky guest ...
... an Arizona-based biotech company is testing out OraTest, its detection ... is a disfiguring entity // that is caused by chewing ... that nearly 30,000 people are diagnosed with oral cancer every ... into perspective when he said, "We are subduing the dangers ...
... at the Picower Institute for Learning and Memory shows that neurons ... earlier concept of adult brain // lacks the capacity to grow ... avenues to research on the various techniques that could induce growth ... like the genetic or the sensory or by other ways that ...
... conducted by Crimmins and Finch showed the effect of ... of developing cardiovascular diseases // . ,They ... Sweden, France, England and Switzerland from different years but ... 1900 modern medicine was an important factor in treating ...
Cached Medicine News:Health News:More The Usage More The Growth In The Adult Brain. 2
... the visual field is examined with an ... By overlapping the ocular fundus image and ... correspondence between the two., ,The data integrates ... practices to totally manage the fundus images ...
SkinStation, powered by LHE, is Radiancys flagship product. A powerhouse by design, it incorporates todays most sought after applications all on one user-friendly system ....
Inquire...
The HYRYS™ 2 densitometer is reflective of Sebia's expertise in the development and design of imaging systems and densitometers utilized in the electrophoresis field....
Medicine Products: